Feider Stephen, Chief Financial Officer, has demonstrated a clear selling bias in recent insider transactions, as evidenced by SEC Form 4 filings. Over the course of 27 reported trades, Stephen has sold shares totaling approximately $1.48 million, compared to purchases valued at $306,000. The majority of this activity has been concentrated in shares of BBNX, with no recent buy transactions recorded. Notably, all 12 of Stephen’s most recent trades since August 2025 have been sales, including significant transactions such as a $590,680 sale on January 2, 2026, and a $309,697.68 sale on October 1, 2025. Smaller sales, such as $2,100 on September 5, 2025, and $2,108 on October 1, 2025, also punctuate this trend.
The pattern of selling is further underscored by the absence of any recent acquisitions, with the last recorded buy occurring prior to August 2025. Stephen’s transactions also include multiple instances of shares acquired through derivative securities, such as stock options, which were subsequently sold. For example, on March 2, 2026, Stephen sold shares worth $17,652.36, following an acquisition through derivative securities. This consistent divestment suggests a strategic reduction in holdings, though the filings provide no insight into the rationale behind these decisions. The data reflects a clear directional shift toward reducing exposure to BBNX, with Stephen’s trading activity heavily weighted toward sales over the past year.
AI-assisted summary